Clinical Trials Sponsored by R-Pharm

Total 7985 results

H. Lee Moffitt Cancer Center and Research Institute
Kyowa Hakko Kirin Pharma, Inc.

Recruiting

Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) (PLIGHT)

Mycosis Fungoides

United States
UMC Utrecht
Eli Lilly and Company; Sanofi; AbbVie; LEO Pharma; Academisch Ziekenhuis Groningen

Recruiting

BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients With Atopic Dermatitis (BioDay)

Atopic Dermatitis

Netherlands
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Active, not recruiting

Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer (PROSPER)

Prostate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate Cancer

Hong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Active, not recruiting

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Prostate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate Cancer

Canada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
Zogenix, Inc.
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.

Terminated

European Non-interventional Study on Refractory Epilepsy With Developmental Delay

Refractory Epilepsy | Development Delay

Germany, Spain, France, Italy
Institut Cancerologie de l'Ouest
Astellas Pharma Inc; Direction Générale de l'Offre de Soins

Active, not recruiting

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients (OLIGOPELVIS2)

Prostate Cancer | Oligometastasis

France
Sidney Kimmel Comprehensive Cancer Center at Johns...
Astellas Pharma Inc; Medivation, Inc.

Active, not recruiting

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

Adenocarcinoma of the Prostate

United States
Institut National de la Santé Et de la Recherche...
Innate Pharma

Active, not recruiting

Study of the Immune Response in Colon Adenocarcinoma (IMCO)

Colon Adenocarcinoma

France
Luye Pharma Group Ltd.
Alliance for Clinical Trials in Oncology; Evolution Research Group

Completed

Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients

Schizophrenia Patients

United States
Herlev Hospital
Roche Pharma AG; Bispebjerg Hospital; Copenhagen University Hospital at Herlev; Onxe...

Terminated

A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

Denmark
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)

Castration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the Bone

United States
Simone Lumetti
Geistlich Pharma AG; Dentsply Sirona Implants and Consumables

Unknown

Impact of a Alveolar Ridge Preservation Technique on the Need of Performing Guided Bone Regeneration for Dental Implant Placement

Tooth Avulsion

Italy
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer

Prostate Cancer

Canada, United States
Kangdong Sacred Heart Hospital
Astellas Pharma Korea, Inc.; The Catholic University of Korea

Completed

Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone (RAPA)

Cancer | Tumors

Korea, Republic of
European Organisation for Research and Treatment...
Roche Pharma AG; Amgen

Terminated

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases (BOS2)

Colorectal Cancer Metastatic | Liver Metastases | KRAS Wild Type Colorectal Cancer

France, Belgium, Austria, Netherlands, Spain, Switzerland
Dr. Falk Pharma GmbH
The Swedish Organization for Studies on Inflammatory Bowel Disease

Completed

SOIBD Collagenous Colitis Maintenance Study (SCCMS)

Induction and Maintaining Remission of Collagenous Colitis

Germany, Sweden
Medhat Osman MD
Astellas Pharma US, Inc.

Withdrawn

Feasibility and Diagnostic Accuracy of Myocardial SPECT Using Early Imaging Protocol

Coronary Artery Disease | Atherosclerosis
University of Campinas, Brazil
Conselho Nacional de Desenvolvimento Científico e Tecnológico; ANS Pharma

Unknown

Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

Diabetes Mellitus, Type 2 | Insulin Resistance | Diabetes-Related Complications

Brazil
Georg Hess, MD
Roche Pharma AG; Klinikum Frankfurt Höchst

Completed

Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma (Mz-135)

Relapsed Non-Hodgkin-Lymphoma
Lisa Bax
Roche Pharma AG; Genentech, Inc.

Terminated

Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) (HIPPoS)

Pancreatic Ductal Adenocarcinoma

United Kingdom
University Hospital, Linkoeping
The Swedish Research Council; Ostergotland County Council, Sweden; Pharma Nord

Completed

Intervention With Selenium and Q10 on Cardiovascular Mortality and Cardiac Function in the Elderly Population in Sweden (KiSel-10)

Cardiac Function | Cardiovascular Mortality

Sweden
UMC Utrecht
Leiden University Medical Center; Center for Human Drug Research; TI Pharma

Completed

Investigating the Acute Effects of THC on Functional Brain Systems (FIX)

Magnetic Resonance Imaging | Memory | Reward | Tetrahydrocannabinol | Endocannabinoids

Netherlands
University of California, San Diego
UCB Pharma; The Organization of Teratology Information Specialists

Recruiting

OTIS Autoimmune Diseases in Pregnancy Project

Rheumatoid Arthritis | Psoriasis | Crohn's Disease | Psoriatic Arthritis | Ankylosing Spondylitis

United States
Zogenix, Inc.
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.

Active, not recruiting

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

Dravet Syndrome | Epileptic Encephalopathy | Lennox Gastaut Syndrome

United States, Australia, Belgium, Canada, Denmark, France, Germany, Italy, Mexico, Netherlands, Poland, Spain, Sweden, United Kingdom
Icahn School of Medicine at Mount Sinai
Bristol-Myers Squibb; Traws Pharma, Inc.

Completed

Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

Adenocarcinoma | Non-small Cell Lung Cancer | Stage IV

United States
University of California, Davis
National Cancer Institute (NCI); Astellas Pharma Inc; Medivation, Inc.

Active, not recruiting

Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute
Astellas Pharma US, Inc.; Oregon Health and Science University

Active, not recruiting

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

Castration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7

United States
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients (PLATO)

Prostate Cancer

United States, Australia, Spain, United Kingdom, Denmark, Belgium, Slovakia, Finland, Italy, France, Sweden
Institute of Cancer Research, United Kingdom
AstraZeneca; Astellas Pharma Inc; Prostate Cancer UK

Terminated

Combination Study of AZD5069 and Enzalutamide. (ACE)

Metastatic Castration Resistant Prostate Cancer

United Kingdom, Switzerland
State University of New York - Upstate Medical...
Mitsubishi Tanabe Pharma America Inc.

Enrolling by invitation

Telespirometry in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States
Komagome Hospital
Japan Agency for Medical Research and Development; Prism Pharma Co., Ltd.

Completed

An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis

Hepatitis C Virus-infected Cirrhosis

Japan
Food and Drug Administration (FDA)
Algorithme Pharma Inc; Vince & Associates Clinical Research, Inc.

Completed

A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects

Healthy

United States
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer (PREVAIL)

Prostate Cancer

Canada, United States, Spain, Australia, Denmark, Korea, Republic of, Belgium, Singapore, Finland, Netherlands, France, Austria, Germany, Israel, United Kingdom, Italy, Japan, Lithuania, Poland, Russian Federation, Slovakia, Sweden
Instituto de Investigación Sanitaria de la Fundación...
Biopolis S.L.; Adventia Pharma

Unknown

Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease

Malnutrition | Crohn Disease | Absorption; Disorder | Absorption; Disorder, Protein | Absorption; Disorder, Fat | Absorption; Disorder, Carbohydrate

Spain
Virginia Commonwealth University
Michael J. Fox Foundation for Parkinson's Research; RaQualia Pharma Inc.

Completed

RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease (RQ-10)

Parkinson's Disease | Constipation | Gastroparesis

United States
Nova Immunotherapeutics Limited
The Emmes Company, LLC; Nova Laboratories Limited; Mercia Pharma Inc.

Unknown

The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) (MER4101)

Influenza, Human

United States
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer

Prostate Cancer

United States
Spanish Cooperative Group for the Treatment of...
Roche Pharma AG

Completed

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells (VISNU-1)

Metastatic Colorectal Cancer

Spain
Mitsubishi Tanabe Pharma Corporation
The Research Foundation for Microbial Diseases of Osaka University

Completed

Phase 3 Study of BK1310 in Healthy Infants

Immunization; Infection

Japan
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer (STRIVE)

Prostate Cancer

United States
National Institute of Diabetes and Digestive and...
Roche Pharma AG

Completed

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Chronic Hepatitis C

United States
Techpool Bio-Pharma Co., Ltd.
The First Affiliated Hospital of Guangzhou Medical University

Unknown

The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)

Acute Respiratory Distress Syndrome

China
Timothy Boone, MD, PhD
Astellas Pharma US, Inc.

Completed

Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms

United States
ANS Pharma
University of Campinas, Brazil; Conselho Nacional de Desenvolvimento Científico...

Completed

Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Complications of Diabetes Mellitus

Brazil
Professor David Cunningham
GlaxoSmithKline; Roche Pharma AG; Cancer Research UK

Unknown

Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer (ST03)

Oesophagogastric Cancer

United Kingdom
University of Arkansas
Erasmus Medical Center; The Netherlands Cancer Institute; Biolitec Pharma Ltd.

Terminated

Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers

Squamous Cell Carcinoma of the Head and Neck

United States
PD Dr. med. Volker Heinemann
Roche Pharma AG

Unknown

Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine

Pancreatic Cancer
University of Giessen
Hoffmann-La Roche; Astellas Pharma Inc; Heidelberg University; Aventis Pharmaceuticals

Completed

Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients

Renal Transplantation | Renal Failure, Chronic

Germany
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B

Malaria

Australia

Clinical Trials Sponsored by R-Pharm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations